for the treatment of house dust mite-induced allergic rhinitis, with or without conjunctivitis, to include children ages 5 through 11 years. Odactra is an allergy immunotherapy and is administered ...

Methods for reducing house dust mites have limited clinical benefits despite lowering allergen exposure, a meta-analysis ...

The British Allergy Foundation says house dust mites are one of the three most common triggers for allergies. The other two are mould and pets. To be more specific, allergies are usually triggered ...

The FDA has expanded the approval of Odactra to include treatment of house dust mite-induced allergic rhinitis in pediatric patients aged 5 to 11 years.

An oral immunotherapy designed to treat dust mite allergy, made by Denmark's ALK-Abello, could soon become an option for thousands of people seeking treatment for persistent symptoms through the NHS.

I have a pretty wide variety of allergies. My biggest two or three is pollens and dust mites and dogs and cats. Narrator Obviously you can't keep away from all triggers at all times, but you can ...

ALK (ALKB:DC / OMX: ALK B) today announced that the US Food and Drug Administration (FDA) has approved ALK's ODACTRA ® tablet for use in young children with house dust mite (HDM) allergy.

The change in weather may be welcome, but the allergens that come along with it may cause your cutie's nose to stuff up and eyes to itch. But take heart: Our guide to seasonal allergies in babies and ...

WEDNESDAY, March 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has expanded its indication of Odactra, a house dust mite allergen tablet, for the treatment of house dust ...

Eligible patients had persistent allergic rhinitis symptoms despite receiving allergy pharmacotherapy. In the trial, participants were randomly assigned to receive Odactra (n=693) or placebo (n ...